Processa Pharmaceuticals, Inc. (PCSA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.59M | -2.9M | -3.48M | -2.27M | -2.73M | -2.25M | -3.6M | -3.35M | -2.05M | -2.12M | -1.76M | -2.06M | -2.11M | -2.5M | -2.97M | -2.33M | -1.8M | -2.73M | -1.55M | -2.19M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -31.53% | -29.05% | 3.28% | 32.14% | -33.24% | -5.83% | -104.58% | -62.07% | 3.08% | 14.96% | 40.8% | 11.42% | -17.26% | 8.42% | -91.54% | -6.22% | 19.64% | -19.85% | -5419.72% | -525.82% |
| Net Income | -3.38M | -3.36M | -3.44M | -3.93M | -2.83M | -2.73M | -3.38M | -3.01M | -2.73M | -2.4M | -2.08M | -2.61M | -4.02M | -13.01M | -6.02M | -5.16M | -3.23M | -3.18M | -2.99M | -3.16M |
| Depreciation & Amortization | 301 | 301 | 301 | 301 | 301 | 301 | 203 | 139 | 139 | 140 | 82 | 20.18K | 19.8K | 197.12K | 197.12K | 197.12K | 197.12K | 197.12K | 195.7K | 198.83K |
| Stock-Based Compensation | 95.96K | 0 | 75.34K | 430.96K | 227.71K | 155.05K | 154.19K | 152.63K | 167.64K | 256.82K | 142.89K | 319.12K | 341.5K | 2.78M | 3.21M | 2.01M | 828.9K | 1.15M | 1.08M | 865.32K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -291.78K | 0 | -20.18K | -19.8K | 0 | 0 | 0 | 0 | -181.75K | -122.44K | -137.17K |
| Other Non-Cash Items | 59.82K | -171.64K | 252.03K | -204.29K | 22.94K | 22.48K | 22.03K | 21.3K | 21.37K | 312.76K | 20.57K | 20.18K | 1.33M | 7.33M | 58.34K | 249.23K | 25.67K | 21.75K | 21.3K | 157.1K |
| Working Capital Changes | -369.6K | 629.7K | -375.46K | 1.44M | -146.4K | 303.15K | -394.33K | -509.57K | 488.34K | 3.13K | 157.47K | 208.79K | 235.82K | 216.15K | -423.18K | 378.13K | 372.51K | -730.45K | 255.59K | -121.01K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70.27K | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -216.43K | 329.62K | -58.58K | 233.19K | -328.32K | 169.17K | -241.38K | 497.72K | 143.75K | -34.68K | 107.28K | -77.69K | -10.84K | 16.48K | -337.04K | 332.01K | 97.19K | -136.07K | 67.1K | 110.86K |
| Cash from Investing | -500K | -850K | 0 | 0 | 0 | 0 | -3.24K | 0 | 0 | 0 | -2.78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -500K | -850K | 0 | 0 | 0 | 0 | -3.24K | 0 | 0 | 0 | -2.78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 244.78K | 2.98M | 2.86M | 6.31M | 4.44M | 547.58K | 926.2K | -3.41K | 6.26M | -30.61K | -52.75K | 0 | 6.35M | -53.6K | -35.25K | 0 | -300K | 131.36K | -185.18K | -23.09K |
| Debt Issued (Net) | 0 | 0 | 0 | -1.31K | -1.54K | -1.46K | -1.44K | -1.41K | -895 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 245.1K | 2.98M | 2.86M | 6.32M | 4.44M | 549.36K | 927.63K | -2.01K | 6.27M | 22.14K | -52.75K | 0 | 6.35M | -53.6K | 0 | 0 | -300K | 137.57K | -27.98K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 1.44K | 0 | -1.44K | -312 | -3.66K | -2.01K | -9.92K | 0 | -52.75K | 0 | 0 | -53.6K | 0 | 0 | -300K | -36.42K | -27.98K | 0 |
| Other Financing | -320 | 0 | 0 | -8.96K | 0 | -312 | 0 | 0 | -8.56K | -52.75K | 0 | 0 | 0 | 0 | -35.25K | 0 | 0 | -6.21K | -157.2K | -23.09K |
| Net Change in Cash | -3.85M | -771.47K | -628.2K | 4.04M | 1.71M | -1.7M | -2.68M | -3.35M | 4.21M | -2.15M | -1.82M | -2.06M | 4.24M | -2.55M | -3.01M | -2.33M | -2.1M | -2.6M | -1.74M | -2.22M |
| Free Cash Flow | -3.59M | -2.9M | -3.48M | -2.27M | -2.73M | -2.25M | -3.61M | -3.35M | -2.05M | -2.12M | -1.76M | -2.06M | -2.11M | -2.5M | -2.97M | -2.33M | -1.8M | -2.73M | -1.55M | -2.19M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -31.53% | -29.05% | 3.37% | 32.14% | -33.24% | -5.83% | -104.45% | -62.07% | 3.08% | 14.96% | 40.7% | 11.42% | -17.26% | 8.42% | -91.54% | -6.22% | 19.64% | -19.85% | -5419.72% | -525.82% |
| FCF per Share | -1.37 | -1.13 | -1.83 | -3.65 | -7.16 | -15.20 | -27.52 | -28.04 | -20.77 | -41.29 | -32.66 | -38.32 | -46.42 | -77.87 | -91.80 | -73.10 | -56.94 | -86.85 | -49.99 | -71.20 |
| FCF Conversion (FCF/Net Income) | 1.06x | 0.86x | 1.01x | 0.58x | 0.96x | 0.82x | 1.06x | 1.11x | 0.75x | 0.88x | 0.85x | 0.79x | 0.53x | 0.19x | 0.49x | 0.45x | 0.56x | 0.86x | 0.52x | 0.69x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |